General Information of Drug (ID: DR2206)
Drug Name
DB-041901
Synonyms
Pursennid; Senekot; Senna-lax; Sennaglucosides; Sennosides; Sennoside A&B; Sennoside [JAN]; Sennosides A and B; sennoside; (9,9'-Bianthracene)-2,2'-dicarboxylic acid, 5,5'-bis(beta-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-; 5,5'-Bis(beta-D-glucopyranosyloxy)-4,4'-dihydroxy(9,9'-bianthrachinon)-2,2'-dicarbonsaeure; 5,5'-Bis(beta-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo(9,9'-bianthracene)-2,2'-dicarboxylic acid; 517-43-1; C42H38O20; EINECS 208-238-9; SENNA
Indication Opioid-induced constipation [ICD11: DB32] Phase 2 [1]
Structure
3D MOL is unavailable 2D MOL
Pharmaceutical Properties Molecular Weight 862.7 Topological Polar Surface Area 348
Heavy Atom Count 62 Rotatable Bond Count 9
Hydrogen Bond Donor Count 12 Hydrogen Bond Acceptor Count 20
Cross-matching ID
PubChem CID
5199
CAS Number
517-43-1
Formula
C42H38O20
Canonical SMILES
C1=CC2=C(C(=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)OC7C(C(C(C(O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O
InChI
1S/C42H38O20/c43-11-23-31(47)35(51)37(53)41(61-23)59-21-5-1-3-15-25(17-7-13(39(55)56)9-19(45)27(17)33(49)29(15)21)26-16-4-2-6-22(60-42-38(54)36(52)32(48)24(12-44)62-42)30(16)34(50)28-18(26)8-14(40(57)58)10-20(28)46/h1-10,23-26,31-32,35-38,41-48,51-54H,11-12H2,(H,55,56)(H,57,58)
InChIKey
IPQVTOJGNYVQEO-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
8-glucosyl-rheinanthrone DM006856 N. A. Unclear 1 [3]
Sennidin-8-monoglucoside DM006852 N. A. Hydrolysis - Hydrolysis 1 [4]
Rhein DM006855
10168
Unclear 2 [3]
Sennidins DM006853 N. A. Unclear 2 [3]
Rheinanthrone DM006854
119396
Unclear 3 [5]
Rhein DM006855
10168
Oxidation - Oxidationn 4 [5]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR007439 DB-041901 Sennidin-8-monoglucoside Hydrolysis - Hydrolysis bglA [4]
MR007443 DB-041901 8-glucosyl-rheinanthrone Unclear Unclear [3]
MR007444 8-glucosyl-rheinanthrone Rhein Unclear Unclear [3]
MR007440 Sennidin-8-monoglucoside Sennidins Unclear Unclear [3]
MR007441 Sennidins Rheinanthrone Unclear bglA [5]
MR007442 Rheinanthrone Rhein Oxidation - Oxidationn Unclear [5]
⏷ Show the Full List of 6 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Beta-glucosidase (bglA) DME1842 Bacteroides thetaiotaomicron
A0A0P0FEZ9_BACT4
3.2.1.21
[2]
References
1 ClinicalTrials.gov (NCT02239510) Efficacy of Linaclotide to Senna for CIC
2 Gut microbiota-mediated drug-antibiotic interactions. Drug Metab Dispos. 2015 Oct;43(10):1581-9.
3 Metabolism of sennosides by human intestinal bacteria
4 The action of sennosides and related compounds on human colon and rectum
5 Rheinanthrone, a metabolite of sennoside A, triggers macrophage activation to decrease aquaporin-3 expression in the colon, causing the laxative effect of rhubarb extract

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.